These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8325838)

  • 1. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect.
    Gemmell CH; Sefton MV; Yeo EL
    J Biol Chem; 1993 Jul; 268(20):14586-9. PubMed ID: 8325838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein IIb-IIIa and RGD(S) are not important for fibronectin-dependent platelet adhesion under flow conditions.
    Nievelstein PF; Sixma JJ
    Blood; 1988 Jul; 72(1):82-8. PubMed ID: 2968824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
    Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
    Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
    Mousa SA; Bozarth J; Forsythe M; Tsao P; Pease L; Reilly TM
    Life Sci; 1994; 54(16):1155-62. PubMed ID: 8152339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
    Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus.
    Carr ME; Carr SL; Hantgan RR; Braaten J
    Thromb Haemost; 1995 Mar; 73(3):499-505. PubMed ID: 7667835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
    Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of glycoprotein IIb-IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations.
    Lages B; Weiss HJ
    Blood; 1994 May; 83(9):2549-59. PubMed ID: 8167340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
    J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS; Shattil SJ; Power JW; Gartner TK
    J Biol Chem; 1988 Sep; 263(26):12948-53. PubMed ID: 3417645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
    Cox AD; Devine DV
    Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glanzmann's thrombasthenia: a rare example of an integrin deficit].
    Perutelli P; Mori PG
    Recenti Prog Med; 1992 Oct; 83(10):577-81. PubMed ID: 1462042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes.
    Cramer EM; Savidge GF; Vainchenker W; Berndt MC; Pidard D; Caen JP; Massé JM; Breton-Gorius J
    Blood; 1990 Mar; 75(6):1220-7. PubMed ID: 2310822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity--a comparison with Scott syndrome.
    Weiss HJ; Lages B
    Blood; 1997 Mar; 89(5):1599-611. PubMed ID: 9057642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
    Fournier DJ; Kabral A; Castaldi PA; Berndt MC
    Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies.
    Ginsberg MH; Frelinger AL; Lam SC; Forsyth J; McMillan R; Plow EF; Shattil SJ
    Blood; 1990 Nov; 76(10):2017-23. PubMed ID: 2242424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia.
    Modderman PW; van Mourik JA; van Berkel W; Cordell JL; Morel MC; Kaplan C; Ouwehand WH; Huisman JG; von dem Borne AE
    Br J Haematol; 1989 Dec; 73(4):514-21. PubMed ID: 2611137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation and inhibition of malarial cytoadherence by the anti-CD36 IgM monoclonal antibody NL07.
    Alessio M; Greco NJ; Primo L; Ghigo D; Bosia A; Tandon NN; Ockenhouse CF; Jamieson GA; Malavasi F
    Blood; 1993 Dec; 82(12):3637-47. PubMed ID: 7505121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.